Fri, Aug 29, 2014, 5:55 AM EDT - U.S. Markets open in 3 hrs 35 mins

Recent

% | $
Quotes you view appear here for quick access.

Cytosorbents Corporation Message Board

  • kenve62 kenve62 Mar 20, 2013 11:52 AM Flag

    ping has a great post #4142 on ihub CTSO.

    Check it out!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I expect to hear more of these encouraging reports in the near future.

    • ken I can't find it could u post it here

      • 3 Replies to musbtheplace
      • part 2:
        abdominal inflammation and severe pain, while causing a systemic inflammatory response and frequently organ failure. Despite having a high expected mortality rate, the extent of treatment is typically limited to pain control and hydration. This seriously ill patient was in hemodynamic shock with severe lung injury on mechanical ventilation, and had a high predicted mortality of approximately 40%. His IL-6 level was greater than 900 pg/mL. The patient, whose physicians initially commented that they thought might not survive, recovered following treatment with CytoSorb, and was discharged from the ICU in about 2 weeks. A third example was during the food-borne enterohemorrhagic E. coli (EHEC) outbreak in Germany earlier in 2011 that infected thousands and killed 45 people. CytoSorb™ was used to treat a very ill woman infected with EHEC in a near coma with severe bloody diarrhea, and hemolytic uremic syndrome with renal failure. When treated multiple times with CytoSorb™ after plasmapheresis, she survived and eventually made a full recovery. These 3 individual cases are anecdotal, and should be considered in that context, but provide an early example of the variety of critical-care illnesses that CytoSorb may potentially have a positive effect on. "

        And lets not forget some more recent examples from the recent Jan 2013 SHL:
        "Outside of the trial, in every day clinical practice, physicians have had generally encouraging results with CytoSorb®. For example, there have been a number of cases of septic shock and multiple organ failure where CytoSorb® was used in patients with extremely high cytokine levels (e.g. IL-6 greater than 20,000 pg/ml). These patients were extremely sick with a variety of infections ranging from a Streptococcal limb infection to suspected gram negative sepsis following complications from a gynecologic procedure. In each of these cases, the prognosis was reportedly grim by the treating physicians. With CytoSorb® treatment, IL-6 levels dropped dramatically over the course of several days, with an eventual resolution of organ failure, and patient recovery. Based upon feedback from these physicians, they are interested in documenting these surprising results for potential publication."

      • Must, I'll copy and paste all I can below:
        You must have missed the H1N1 influenza case study on slide 33/34 in the March presentation. The patient had multi-organ failure. He was discharged from the ICU 11 days after the 7-day CytoSorb treatment. Patient was alive and well at 60 day follow up.

        His case study is the same one that showed up in the Jan 2012 SHL:
        "Given this background, we believe that CytoSorb™ is in the right place at the right time, representing a potentially fundamental and revolutionary advance in the treatment of life-threatening illnesses. We have seen CytoSorb™ work in a number of different scenarios. For example, an extremely-ill middle aged man with documented H1N1 influenza infection developed septic shock requiring vasopressors, severe lung injury necessitating mechanical ventilation, and renal failure requiring hemodialysis. His IL-6 level was more than 8,000 pg/mL. This occurred despite treatment with Tamiflu, the standard of care anti-viral treatment for influenza. While undergoing a full 7-day treatment course with CytoSorb™ and additional Tamiflu therapy, his blood pressure stabilized and vasopressor therapy was discontinued. Within days of completing CytoSorb™ therapy, he was weaned from mechanical ventilation, left the ICU, and eventually made a full recovery. A second example was a patient with severe acute pancreatitis. The pancreas is an important digestive organ. It produces bicarbonate to neutralize stomach acid and numerous digestive enzymes that help break down fats, sugars, and proteins. When the duct that carries these enzymes and digestive juices to the small intestine becomes blocked, these agents can begin to auto-digest the pancreas and surrounding tissues, leading to massive abdominal

      • just type in ihub ctso in your search and click on ihub ctso message link, scroll down to messages. Best I can do for you, sorry!

        Sentiment: Strong Buy

    • I saw that, I like my comment better. You? LOL LOL

    • I saw that....bottom line is products like Cytosorb don't go away after results like this...either you're on board this train or waving goodbye from the station

 
CTSO
0.237-0.003(-1.25%)Aug 28 3:58 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.